Answers are grounded in this paper and cite their sources.
Sudden Cardiac Death (SCD), a major cause of cardiovascular mortality globally, refers to an unexpected death from a cardiac cause, usually occurring within an hour of the onset of symptoms1. Identification of individuals at risk is pivotal to reduce its burden. However, this is challenging due to the abrupt onset, with SCD being the first cardiac event in a quarter of victims2. Furthermore, outcomes for these patients are poor because the majority are unable to receive treatment in time3. The 12-lead electrocardiogram (ECG) is limited by the requirement for medical settings and representing only a single moment in time. A smart wearable is defined as an electronic device that can be worn and intermittently or continuously collects and exports health data4, 5. The smart wearable market is expanding rapidly, with an estimated 40% of the UK population owning these devices6. The rise of smart wearables, capable of recording ECGs (most commonly equivalent to lead I), offers the opportunity of remote cardiac monitoring5, 7. The aim of this review was to explore ECG predictors of SCD and their potential applicability to smart wearable devices. A systematic review design based on the PRISMA guidelines was used to comprehensively explore the recent evidence on ECG predictors of SCD and their potential applications in smart wearables8 (Figure 1). Results were obtained by searching Embase, Ovid Medline, EBM and PubMed. Inclusion and exclusion criteria were applied to identify eligible studies. The search yielded 350 results. A further seven papers were identified through citation searching. Following screening and eligibility assessment, 16 papers were identified and included in the review (Table 1). These were a mixture of retrospective case control studies (n = 6), retrospective cohort studies (n = 2) and prospective cohort studies (n = 8). Five ECG parameters were identified in association with SCD: T-wave morphology (TWM), QT interval, T-peak to T-end (TpTe) interval, T-wave alternans (TWA) and QRS duration. TWM was the ECG parameter with the most potential, as it had the strongest independent association with SCD and was successfully measured using lead I in large scale studies (Table 1). The TpTe interval was also highly correlated with SCD, however it has yet to be determined if it can be accurately measured on smart wearables. TWA was consistently associated with SCD, and its measurement has been proven to be feasible on smart wearables. The QT interval had varying significance in this review. The QT interval, prolongation of which is associated with SCD, had varying significance in this review, as it missed genetically proven but concealed long QT syndrome patients (normal QT interval). QRS duration had limited utility as a predictor of SCD. Identifying those at risk of SCD, provides a crucial opportunity for early detection and timely intervention. These findings highlight the potential and limitations of smart wearables in reducing the burden of SCD. However, further research is essential for clinical implementation.
No takes yet. Share an insight, caveat, or question.
Chloe Lord (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: